Vaping cessation has emerged as a pressing public health issue, particularly among teens and young adults.Research conducted by Harvard-affiliated Mass General Brigham shows that an FDA-approved smoking cessation medication, varenicline, significantly boosts the success rate of quitting vaping, with participants being three times more likely to overcome their addiction compared to those who only received behavioral support.